Elisa Agostinetto: Recent findings from MonarchE and NataLEE trials

Elisa Agostinetto, Medical Research Fellow at Brussels University Hospital, recently posted X/Twitter:

“Adjuvant CDK4/6i for early breast cancer: how to choose wisely⁉️
In this work, we discuss the most recent findings from MonarchE and NataLEE trials and put them in perspective for potential use in clinical practice.”

For the article click here.
Source: Elisa Agostinetto/Twitter